Innovative Strategies for Drug Delivery to the Ocular Posterior Segment

Innovative Strategies for Drug Delivery to the Ocular Posterior Segment

Innovative and new drug delivery systems (DDSs) have recently been developed to vehicle treatments and drugs to the ocular posterior segment and the retina. New formulations and technological developments, such as nanotechnology, novel matrices, and non-traditional treatment strategies, open new per...

Full description

Bibliographic Details
Main Authors:	Andrea Gabai, Marco Zeppieri, Lucia Finocchio, Carlo Salati
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Pharmaceutics
Subjects:	drug delivery systems (DDSs) nanotechnology matrices ocular posterior segment vitreoretinal
Online Access:	https://www.mdpi.com/1999-4923/15/7/1862

Similar Items

Current Trends in ATRA Delivery for Cancer Therapy
by: Maria Valeria Giuli, et al.
Published: (2020-07-01)

Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment
by: Hui Jiang, et al.
Published: (2023-12-01)

Toxic posterior segment syndrome with retinal vasculitis likely caused by intraocular cotton fiber after vitreoretinal surgery – a case report
by: Chaitra Jayadev, et al.
Published: (2023-11-01)

Non-Invasive Iontophoretic Delivery of Cytochrome c to the Posterior Segment and Determination of Its Ocular Biodistribution
by: Laura Gisela González Iglesias, et al.
Published: (2022-08-01)

The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems
by: Federica Foglietta, et al.
Published: (2021-11-01)

Lipid Nanoparticles for the Posterior Eye Segment
by: Lorena Bonilla, et al.
Published: (2021-12-01)

Nanocarriers for ocular drug delivery: Recent advances and future opportunities
by: Chetan S Amrutkar, et al.
Published: (2023-01-01)

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
by: Eliana B. Souto, et al.
Published: (2019-09-01)

Comprehensive Proteomic Profiling of Vitreous Humor in Ocular Sarcoidosis Compared with Other Vitreoretinal Diseases
by: Hiroyuki Komatsu, et al.
Published: (2022-06-01)

Novel electrospun implants of Sunitinib can depress ex-vivo ocular neovascularization
by: Deepakkumar Mishra, et al.
Published: (2022-11-01)

Penetration Enhancers for Topical Drug Delivery to the Ocular Posterior Segment—A Systematic Review
by: Abhinav Thareja, et al.
Published: (2021-02-01)

Ocular manifestations in HIV patients attending a tertiary care hospital in Eastern India and correlation of posterior segment lesions with CD4+ counts
by: Jyotirmayee Swain, et al.
Published: (2023-01-01)

DELIVERY OF DRUGS TO THE POSTERIOR EYE SEGMENT USING BIODEGRADABLE MULTILAYER IMPLANT
by: Y. A. Belyy, et al.
Published: (2015-10-01)

Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
by: Shiding Li, et al.
Published: (2023-07-01)

Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan
by: Ayah Mohammad Burhan, et al.
Published: (2021-10-01)

Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders
by: Xuan Chen, et al.
Published: (2023-01-01)

Topical Drug Delivery to the Posterior Segment of the Eye
by: Marina Löscher, et al.
Published: (2022-01-01)

Ocular hemodynamics in patients with posterior uveitis entities
by: N. I. Khramenko, et al.
Published: (2022-03-01)

Neuroprotective Nanoparticles Targeting the Retina: A Polymeric Platform for Ocular Drug Delivery Applications
by: Patrizia Colucci, et al.
Published: (2023-03-01)

Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives
by: Siphokazi B. K. Dludla, et al.
Published: (2022-08-01)

Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies
by: Felipe M. González-Fernández, et al.
Published: (2023-01-01)

Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field
by: Elide Zingale, et al.
Published: (2022-04-01)

Frequency of vitreoretinal adhesion in retinal vessels in patients with axial myopia of different age groups
by: O. V. Kolenko, et al.
Published: (2020-10-01)

Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye
by: Yaru Wang, et al.
Published: (2022-05-01)

Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems
by: Kevin Y. Wu, et al.
Published: (2023-03-01)

Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery
by: Kevin Y. Wu, et al.
Published: (2023-09-01)

Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
by: Alexander Vaneev, et al.
Published: (2021-11-01)

Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye
by: Manuela Santonocito, et al.
Published: (2021-04-01)

An Injectable Nano-Enabled Thermogel to Attain Controlled Delivery of p11 Peptide for the Potential Treatment of Ocular Angiogenic Disorders of the Posterior Segment
by: Lisa Claire du Toit, et al.
Published: (2021-01-01)

Overview of Recent Advances in Nano-Based Ocular Drug Delivery
by: Li-Ching Liu, et al.
Published: (2023-10-01)

Utility of High-Resolution Ultrasonography in the Evaluation of Posterior Segment Ocular Lesions Using Sensitivity and Specificity
by: Deb K. Boruah, et al.
Published: (2023-10-01)

Erratum to: Impacts of Nanomedicines in Ocular Pharmacotherapy [BioImpacts, 2011, 1(1), 7-22]
by: Ailar Nakhlband, et al.
Published: (2012-03-01)

Membrane Vesicles as Drug Delivery Systems: Source, Preparation, Modification, Drug Loading, In Vivo Administration and Biodistribution, and Application in Various Diseases
by: Chenhan Sun, et al.
Published: (2023-07-01)

Progress in the diagnosis of ocular sarcoidosis
by: Ghazala A Datoo O'Keefe, et al.
Published: (2022-01-01)

Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases
by: Liron Naftali Ben Haim, et al.
Published: (2021-06-01)

Macro-microscopic study of posterior vitreous detachment variants in an ex vivo experiment
by: N. M. Kislitsyna, et al.
Published: (2021-01-01)

Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery
by: Carlo Astarita, et al.
Published: (2021-06-01)

Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
by: Hyeong Min Kim, et al.
Published: (2021-01-01)

Corrigendum: Ocular manifestations of HIV and AIDS patients on antiretroviral therapy in a tertiary hospital in South Africa
by: Prisilla S. Makunyane, et al.
Published: (2022-06-01)

Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
by: Nguyễn Thị Thanh Nhàn, et al.
Published: (2023-04-01)